Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies-Reference-Cited by-同舟云学术

Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies

Published:2017-09 Issue: Volume:83 Page:237-246
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ciccarese Chiara,Iacovelli Roberto^ORCID,Brunelli Matteo,Massari Francesco,Bimbatti Davide,Fantinel Emanuela,De Marco Vincenzo,Porcaro Antonio Benito,Martignoni Guido,Artibani Walter,Tortora Giampaolo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. The International Society of Urological Pathology (ISUP) Vancouver classification of Renal neoplasia;Srigley;Am J Surg Pathol,2013

2. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours;Moch;Eur Urol,2016

3. New molecular targets in non clear renal cell carcinoma: an overview of ongoing clinical trials;Ciccarese;Cancer Treat Rev,2015

4. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria;Kroeger;Cancer,2013

5. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study);International Journal of Cancer;2024-09-07

2. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-04-18

3. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update;Journal of Cancer Research and Clinical Oncology;2024-04-09

4. Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma;Oncogene;2024-03-11

5. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024;Journal of the National Comprehensive Cancer Network;2024-02